![Peter David Suzdak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter David Suzdak
Director/Miembro de la Junta en Acidophil LLC .
Cargos activos de Peter David Suzdak
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Acidophil LLC
![]() Acidophil LLC Medical/Nursing ServicesHealth Services Acidophil LLC develops biotechnologies and products in the field of applied genetics and molecular engineering. It uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. The company was founded by Sydney Brenner and Philip Goelet and is headquartered in Lutherville, MD. | Director/Miembro de la Junta | - | - |
Historial de carrera de Peter David Suzdak
Antiguos cargos conocidos de Peter David Suzdak.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
REXAHN PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/06/2013 | 14/11/2018 |
Director Ejecutivo | 31/01/2013 | 14/11/2018 | |
AEOLUS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/06/2004 | 08/05/2013 |
Independent Dir/Board Member | 23/05/2011 | 08/05/2013 | |
Incara Pharmaceuticals Corp. | Director/Miembro de la Junta | - | 09/08/2004 |
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Director Técnico/Científico/I+D | 01/01/2002 | 01/01/2002 |
NOVO NORDISK A/S | Director Técnico/Científico/I+D | 01/01/1995 | 01/01/1995 |
National Institute of Mental Health | Director Técnico/Científico/I+D | 01/01/1988 | 01/01/1988 |
Corridor Pharmaceuticals, Inc.
![]() Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Director Técnico/Científico/I+D | 23/05/2011 | - |
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Director Ejecutivo | 01/01/2006 | - |
Fundador | 31/12/2010 | - | |
Presidente | 31/12/2010 | - | |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | - | - |
Formación de Peter David Suzdak.
St. John's University | Undergraduate Degree |
University of Connecticut | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 12 |
Dinamarca | 2 |
Operativa
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Chief Executive Officer | 3 |
Sectorial
Health Technology | 9 |
Consumer Services | 3 |
Government | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
AEOLUS PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 8 |
---|---|
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Incara Pharmaceuticals Corp. | Health Technology |
Artesian Therapeutics, Inc.
![]() Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Health Technology |
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Rexahn Pharmaceuticals, Inc.
![]() Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
National Institute of Mental Health | Government |
Acidophil LLC
![]() Acidophil LLC Medical/Nursing ServicesHealth Services Acidophil LLC develops biotechnologies and products in the field of applied genetics and molecular engineering. It uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. The company was founded by Sydney Brenner and Philip Goelet and is headquartered in Lutherville, MD. | Health Services |
Corridor Pharmaceuticals, Inc.
![]() Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Health Technology |
- Bolsa de valores
- Insiders
- Peter David Suzdak
- Experiencia